Neuen BL, Ohkuma T, Neal B, Matthews DR, et al. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program. Am J Kidney Dis 2021;77:23-34.
PMID: 32971190